• Users Online: 414
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 9  |  Issue : 3  |  Page : 216-221

Antioxidant and chemotherapeutic effects of trèvo®supplement on benzene-induced leukaemia in murine models

1 Department of Medical Laboratory Science, College of Health Sciences, Ladoke Akintola University of Technology, Osogbo, Osun State, Nigeria
2 Department of Microbiology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia
3 Department of Oral Pathology, DUH, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia
4 Children Welfare Unit, Osun State Hospital Management Board, Asubiaro, Osogbo, Osun State, Nigeria

Correspondence Address:
Olufemi E Akanni
Department of Medical Laboratory Science, College of Health Sciences, Ladoke Akintola University, Ogbomoso, Oyo State
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/AIHB.AIHB_17_19

Rights and Permissions

Introduction: Oxidative stress is largely implicated in a molecular mechanism involving initiation, development and progression of leukaemogenesis. Trévo® supplement is a multiherbal formula produced from various phytonutrients with antioxidant potential. We investigated the antioxidant activities of Trèvo® supplement as a prospect for leukaemia treatment. Materials and Methods: The study was carried out on 36 Wistar rats weighing between 140 g and 160g. They were randomly divided into six groups. Group 1 (positive controls) were induced with 0.2 ml benzene chromosolv solution 48 hourly for 4 consecutive weeks and fed with rat pellets without Trévo® supplement. Group 2 (negative controls) received only rat pellets. Group 3 received only normal dose of Trévo® supplement with rat pellets. Groups 4, 5 and 6 were induced for 4 weeks followed with low-, moderate- and high-dose Trévo® supplement for 3 weeks with rat pellets, respectively. Glutathione (GSH), catalase (CAT), malondialdehyde (MDA), total protein (TP) and gamma-glutamyltransferase (GGT) plasma concentrations were assayed simultaneously. Results: Induction of leukaemia was evidenced in positive controls by elevated total white blood cell counts (marked with lymphocytosis) and mild anaemia with reduced haemoglobin counts. Furthermore, GSH, CAT and TP levels for graded dosages of Trévo®-treated groups (following benzene induction) showed statistically significant elevations (P < 0.05) compared to the benzene-induced positive controls, whereas MDA and GGT levels with high-dose Trévo® treatment showed statistically significant reductions (P < 0.05) compared to the positive controls. Conclusions: Trévo® supplement exhibited profound antioxidant potential indicated by improvement from leukaemia after oral administration. This amelioration is believed to be associated with the nutritional supplement in a dose-dependent manner.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded169    
    Comments [Add]    
    Cited by others 1    

Recommend this journal